Australian Consumer Services Stock News

Westgold Resources (ASX:WGX) is back in focus after reporting a sharp turnaround in its half year to December 2025, with revenues effectively doubling, a swing to profit, higher gold output and fresh capital management moves. See our latest analysis for Westgold Resources. Those stronger half year numbers, the maintenance of production and cost guidance, and the launch of a buyback and dividend have coincided with a 1 day share price return of 1.57% and a 90 day share price return of 27.05%...

Neuren Pharmaceuticals (ASX:NEU) has opened FY 2025 with first half revenue of A$28.3 million and basic EPS of A$0.12, setting a different tone from the prior half, when the company recorded A$192.5 million of revenue and basic EPS of A$1.05. The company has seen revenue move from A$26.2 million and basic EPS of A$0.06 in the first half of FY 2024 to A$28.3 million and A$0.12 in the latest period. Trailing twelve month EPS sits at A$1.17 on revenue of A$218.9 million, giving investors a clear...

Tribeca Global Natural Resources (ASX:TGF) has put a solid marker down with its H1 2026 update, coming off a trailing 12 month run where total revenue was A$147.5 million and EPS reached A$1.09, underpinned by net income of A$84.8 million. Over recent halves the fund has seen revenue move from A$6.9 million and EPS of A$0.01 in H2 2024 to A$29.0 million and EPS of A$0.19 in H2 2025. An earlier H1 2025 stretch included revenue of A$8.7 million and an EPS loss of A$0.13, giving investors a...

Virgin Australia Holdings (ASX:VGN) kicked off H1 2026 results season with trailing twelve month revenue of about A$6.1b and net income of A$346.5m, framing the latest half year print of A$2.7b in revenue and A$5.5m in net income against a period where profitability has already compressed from earlier highs. The company has seen revenue move from A$2.6b in H2 2024 to A$3.0b in H1 2025 and A$2.7b in H2 2025, while net income shifted from A$44.4m to A$473m and then A$5.5m. This leaves investors...

Clarity Pharmaceuticals (ASX:CU6) has posted its H1 2026 scorecard, with investors watching how its revenue base and per share losses are tracking against ambitious growth expectations. The company has seen half year revenue move from A$6.1 million in H2 2024 to A$4.7 million in H1 2025 and A$4.8 million in H2 2025. Over the same periods, basic EPS moved from a loss of A$0.09 per share in H2 2024 to losses of A$0.07 in H1 2025 and A$0.13 in H2 2025. This sets the scene for a results season...

GenusPlus Group (ASX:GNP) has drawn fresh attention after reporting half year sales of A$535.42 million and net income of A$24.88 million, alongside affirming a fully franked A$0.02 interim dividend. See our latest analysis for GenusPlus Group. Investors appear to be reacting to the stronger half year earnings and confirmed dividend, with the A$7.80 share price sitting on a 25.8% year to date share price return and a very large multi year total shareholder return that suggests momentum has...

Helia Group (ASX:HLI) has put capital returns in the spotlight by pairing its 2025 earnings announcement with a fully franked final ordinary dividend and a large partially franked special dividend to shareholders. See our latest analysis for Helia Group. At a share price of A$6.02, Helia’s recent capital return announcements and 2025 earnings update come after a 90 day share price return of 6.55%, while the 5 year total shareholder return of 390.50% points to momentum that has, so far,...

In February 2026, Uber Technologies announced an expanded strategic partnership with Life360, enabling account linking across Life360, Uber, and Uberteen for integrated ride booking, real-time trip tracking, and shared membership benefits to support family coordination and safety. This deeper integration reinforces Life360’s ambition to become a broader “family super app,” centralizing everyday services families use across both iOS and Android. Next, we’ll examine how Life360’s expanded Uber...

Clinuvel Pharmaceuticals (ASX:CUV) is in focus after a key European Medicines Agency approval for year round SCENESSE use in erythropoietic protoporphyria, alongside fresh half year earnings that show revenue of A$40.56 million and net income of A$10.44 million. See our latest analysis for Clinuvel Pharmaceuticals. Even with the EMA approval and fresh half year numbers, sentiment around Clinuvel looks cautious. A 1 day share price return of 9.33% decline and a year to date share price return...

Why Bapcor’s latest earnings and capital raise matter for shareholders Bapcor (ASX:BAP) has combined a half year result that moved from net income to a loss with a planned A$200 million follow on equity offering, putting its balance sheet and capital plans in sharp focus. See our latest analysis for Bapcor. The earnings swing to a net loss and the planned A$200 million rights offering have coincided with a sharp reset in expectations. The 30 day share price return of 59.91% and 1 year total...

Aurelia Metals (ASX:AMI) is back in focus after releasing its half year FY26 results, showing higher revenue, EBITDA and net income, backed by updated production data across its gold and base metals operations. See our latest analysis for Aurelia Metals. The latest half year earnings and production update comes after a 29.79% 90 day share price return and a 52.50% 1 year total shareholder return. In contrast, the 5 year total shareholder return of a 9.94% decline shows longer term investors...

Supply Network (ASX:SNL) has drawn fresh attention after reporting half year earnings to December 31, 2025, with sales of A$200.14 million and net income of A$22.86 million compared to a year earlier. See our latest analysis for Supply Network. The earnings update and recent director share purchase have come alongside mixed share price momentum. There has been a 10.59% year to date share price return, contrasting with a 7.91% 1 month decline and a very large 5 year total shareholder return,...

AUB Group (ASX:AUB) is back in focus after a busy half year that combined higher underlying profit, an upgraded full year earnings guidance range, a higher fully franked interim dividend, and a leadership change in the finance team. See our latest analysis for AUB Group. Despite the upbeat half year earnings, higher dividend and ongoing acquisition plans, AUB Group's 30 day share price return of 16.64% decline and 90 day share price return of 31.97% decline indicate fading momentum. However,...

G8 Education (ASX:GEM) is back in focus after reporting a statutory net loss of A$303.31 million for 2025, with impairment charges and operating cost pressures sharpening questions about its turnaround prospects and sector recovery. See our latest analysis for G8 Education. The earnings announcement and statutory loss have coincided with sharp share price pressure. G8 Education’s 30 day share price return of 49.62% and 1 year total shareholder return of 74.43% decline point to fading momentum...

Resolute Mining Limited has reported its full-year 2025 results, moving from a prior-year net loss of US$28.3 million to net income of US$110.4 million and returning to positive earnings per share from continuing operations. This earnings turnaround coincides with continued progress at the Doropo project in Côte d’Ivoire and reaffirmed 2026 production guidance of 250,000 to 275,000 ounces at an all-in sustaining cost of US$2,000 to US$2,200 per ounce, underscoring the company’s current...

Mesoblast (ASX:MSB) opened H1 2026 with revenue of US$14.0 million and a basic EPS loss of US$0.04, while trailing 12 month figures in the dataset show revenue of US$65.4 million and a net loss of US$94.4 million. The company has seen revenue move from US$2.5 million in H2 2024 to US$3.2 million in H1 2025 and then to US$14.0 million in H2 2025, with basic EPS losses in those periods ranging between US$0.04 and US$0.05. The latest results therefore keep the focus on how quickly revenue can...

Why Computershare’s latest guidance shift matters for investors Computershare (ASX:CPU) has raised its fiscal 2026 earnings guidance and lifted its interim dividend, even as tariff related volatility and interest rate sensitivity continue to weigh on market sentiment toward the stock. See our latest analysis for Computershare. Despite the upgraded fiscal 2026 guidance and higher interim dividend, the 30 day share price return of a 9.76% decline and 90 day share price return of a 13.68%...

Technology One Limited recently increased its FY26 guidance, forecasting higher profit before tax growth and stronger annual recurring revenue, reflecting confidence in SaaS and SaaS+ demand across Australia, New Zealand and the UK. This guidance upgrade comes alongside ongoing board evolution and insider share purchases, underscoring management’s alignment with and commitment to the company’s SaaS-focused trajectory. We’ll now explore how the upgraded profit and recurring revenue guidance...

Northern Star Resources (ASX:NST) has attracted fresh attention after a sector wide gold rally lifted its share price, with investors now eyeing the upcoming ex-dividend date and quarterly update as key nearer term catalysts. See our latest analysis for Northern Star Resources. That recent gold driven bump fits into a strong run, with Northern Star’s share price delivering a 23.95% year to date gain and a 1 year total shareholder return of 81.72%. The 3 and 5 year total shareholder returns of...

In February 2026, Brambles Limited reported half-year results showing higher sales of US$3,533.5 million and net income of US$510.8 million, alongside increased earnings per share compared with the previous year. At the same time, Brambles slightly lowered its full-year 2026 sales growth guidance and lifted its interim dividend to US$0.23 per share, highlighting a mix of improving profitability and more cautious revenue expectations. We’ll now examine how Brambles’ stronger earnings but...

Why Paladin Energy’s EIS approval matters for investors Paladin Energy (ASX:PDN) has secured Ministerial approval for its Environmental Impact Statement on the Patterson Lake South uranium project in Canada, a key regulatory step toward potential construction and eventual operation. The approval under Saskatchewan’s Environmental Assessment Act follows technical acceptance in June 2025 and a public review period from July to September. This clears an important hurdle before provincial and...

Charter Hall Group (ASX:CHC) is back in focus after upgraded fiscal 2026 guidance for higher post tax operating earnings and distribution growth, combined with strong half year results and the appointment of a new independent non executive director. See our latest analysis for Charter Hall Group. At a latest share price of A$22.07, Charter Hall Group has seen a 1 day share price return of 1.33%, while the 30 day and year to date share price returns of 6.20% and 9.70% compare with a 1 year...

Macquarie Technology Group (ASX:MAQ) opened H1 2026 with A$186.0 million in revenue and net income of A$16.9 million, translating to basic EPS of A$0.66 as investors weigh these results against a share price of A$67.89. The company reported revenue of A$182.0 million in H2 2024, A$183.6 million in H1 2025 and A$186.0 million in H2 2025, while basic EPS moved from A$0.74 to A$0.70 and then A$0.66 over the same periods. This provides a clear backdrop for how current margins are being...

Stanmore Resources reported its 2025 full-year results, with revenue easing to US$1,885.6 million and the company moving from a prior profit to a US$47.2 million net loss, while still declaring a fully franked final dividend of about US$0.089 per share payable in March 2026. Despite weaker earnings and softer coal prices, Stanmore lifted coal output to record levels, maintained strong liquidity, and confirmed stable coal reserves and resources, underscoring management’s confidence in the...